Statistics
Publications
8
Citations
1.6K
H-Index
8
Active since
2013
Affiliations
Novartis (United States)(Current)
Mark Palermo is an author at Novartis (United States) specializing in drug design, pharmacology, and drug discovery.
Publications per year
2013–2024
8
8
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
Michael D. Shultz, Atwood K. Cheung, C.A. Kirby et al. · Journal of Medicinal Chemistry · 2013 · 123 citations · Full text
1–5 of 8